Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Mar 7, 2017, after the close
10-K filed Mar 7, 2017, 66 days after period end · 0001558370-17-001428
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Net Income | -$15.59M | — | — | — |
| EPS Diluted | -$0.16 | -$0.14 | -$0.25 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2016 · filed Mar 7, 2017 · 66 d after period end
+4.6% from the close of Mar 7, 2017 to the close of Mar 8, 2017, the first after the release.
